Novel anti-inflammatory drugs for the treatment of diabetic kidney disease

Diabetologia. 2016 Aug;59(8):1621-3. doi: 10.1007/s00125-016-4030-4. Epub 2016 Jun 23.

Authors

Hiddo J L Heerspink¹, Dick De Zeeuw²

Affiliations

¹ Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, PO Box 30001, 9700 RB, Groningen, the Netherlands. h.j.lambers.heerspink@umcg.nl.
² Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, PO Box 30001, 9700 RB, Groningen, the Netherlands.

No abstract available

Keywords: CCL2; Diabetic kidney disease; Inflammation; JAK-STAT; MCP-1.

Publication types

Review
Comment

MeSH terms

Anti-Inflammatory Agents*
Chemokine CCL2
Diabetic Nephropathies*
Humans
Kidney

Substances

Anti-Inflammatory Agents
Chemokine CCL2